Antibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- Other assay [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 37-3200 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- Epha3 Monoclonal Antibody (5E11F2)
- Antibody type
- Monoclonal
- Antigen
- Synthetic peptide
- Reactivity
- Human, Rat
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- 5E11F2
- Vial size
- 100 µg
- Concentration
- 0.5 mg/mL
- Storage
- -20°C
Submitted references Engineering Novel Lentiviral Vectors for Labelling Tumour Cells and Oncogenic Proteins.
Cancer somatic mutations disrupt functions of the EphA3 receptor tyrosine kinase through multiple mechanisms.
Akgül S, Offenhäuser C, Kordowski A, Day BW
Bioengineering (Basel, Switzerland) 2022 Feb 25;9(3)
Bioengineering (Basel, Switzerland) 2022 Feb 25;9(3)
Cancer somatic mutations disrupt functions of the EphA3 receptor tyrosine kinase through multiple mechanisms.
Lisabeth EM, Fernandez C, Pasquale EB
Biochemistry 2012 Feb 21;51(7):1464-75
Biochemistry 2012 Feb 21;51(7):1464-75
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- NULL
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- NULL